Literature DB >> 18469813

X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment.

Leanne M Dibbens1, Patrick S Tarpey, Kim Hynes, Marta A Bayly, Ingrid E Scheffer, Raffaella Smith, Jamee Bomar, Edwina Sutton, Lucianne Vandeleur, Cheryl Shoubridge, Sarah Edkins, Samantha J Turner, Claire Stevens, Sarah O'Meara, Calli Tofts, Syd Barthorpe, Gemma Buck, Jennifer Cole, Kelly Halliday, David Jones, Rebecca Lee, Mark Madison, Tatiana Mironenko, Jennifer Varian, Sofie West, Sara Widaa, Paul Wray, John Teague, Ed Dicks, Adam Butler, Andrew Menzies, Andrew Jenkinson, Rebecca Shepherd, James F Gusella, Zaid Afawi, Aziz Mazarib, Miriam Y Neufeld, Sara Kivity, Dorit Lev, Tally Lerman-Sagie, Amos D Korczyn, Christopher P Derry, Grant R Sutherland, Kathryn Friend, Marie Shaw, Mark Corbett, Hyung-Goo Kim, Daniel H Geschwind, Paul Thomas, Eric Haan, Stephen Ryan, Shane McKee, Samuel F Berkovic, P Andrew Futreal, Michael R Stratton, John C Mulley, Jozef Gécz.   

Abstract

Epilepsy and mental retardation limited to females (EFMR) is a disorder with an X-linked mode of inheritance and an unusual expression pattern. Disorders arising from mutations on the X chromosome are typically characterized by affected males and unaffected carrier females. In contrast, EFMR spares transmitting males and affects only carrier females. Aided by systematic resequencing of 737 X chromosome genes, we identified different protocadherin 19 (PCDH19) gene mutations in seven families with EFMR. Five mutations resulted in the introduction of a premature termination codon. Study of two of these demonstrated nonsense-mediated decay of PCDH19 mRNA. The two missense mutations were predicted to affect adhesiveness of PCDH19 through impaired calcium binding. PCDH19 is expressed in developing brains of human and mouse and is the first member of the cadherin superfamily to be directly implicated in epilepsy or mental retardation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18469813      PMCID: PMC2756413          DOI: 10.1038/ng.149

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  24 in total

1.  delta-Protocadherins: a gene family expressed differentially in the mouse brain.

Authors:  K Vanhalst; P Kools; K Staes; F van Roy; C Redies
Journal:  Cell Mol Life Sci       Date:  2005-06       Impact factor: 9.261

Review 2.  The cadherin superfamily in neuronal connections and interactions.

Authors:  Masatoshi Takeichi
Journal:  Nat Rev Neurosci       Date:  2006-11-29       Impact factor: 34.870

3.  Expression of the delta-protocadherin gene Pcdh19 in the developing mouse embryo.

Authors:  Yaned Gaitan; Maxime Bouchard
Journal:  Gene Expr Patterns       Date:  2006-03-03       Impact factor: 1.224

4.  Structure of the cadherin-related neuronal receptor/protocadherin-alpha first extracellular cadherin domain reveals diversity across cadherin families.

Authors:  Hirofumi Morishita; Masataka Umitsu; Yoji Murata; Naoki Shibata; Keiko Udaka; Yoshiki Higuchi; Hideo Akutsu; Tohru Yamaguchi; Takeshi Yagi; Takahisa Ikegami
Journal:  J Biol Chem       Date:  2006-08-17       Impact factor: 5.157

5.  Spatiotemporal expression pattern of non-clustered protocadherin family members in the developing rat brain.

Authors:  S-Y Kim; H Sun Chung; W Sun; H Kim
Journal:  Neuroscience       Date:  2007-07-05       Impact factor: 3.590

6.  Functional implication of truncated P-cadherin expression in malignant melanoma.

Authors:  Richard Bauer; Anja Katrin Bosserhoff
Journal:  Exp Mol Pathol       Date:  2006-08-17       Impact factor: 3.362

7.  Tissue-specific expression and regulation of sexually dimorphic genes in mice.

Authors:  Xia Yang; Eric E Schadt; Susanna Wang; Hui Wang; Arthur P Arnold; Leslie Ingram-Drake; Thomas A Drake; Aldons J Lusis
Journal:  Genome Res       Date:  2006-07-06       Impact factor: 9.043

8.  Expression and genetic variability of PCDH11Y, a gene specific to Homo sapiens and candidate for susceptibility to psychiatric disorders.

Authors:  Christelle M Durand; Caroline Kappeler; Catalina Betancur; Richard Delorme; Hélène Quach; Hany Goubran-Botros; Jonas Melke; Gudrun Nygren; Nadia Chabane; Franck Bellivier; Andrei Szoke; Franck Schurhoff; Maria Rastam; Henrik Anckarsäter; Christopher Gillberg; Marion Leboyer; Thomas Bourgeron
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-01-05       Impact factor: 3.568

9.  Epilepsy and mental retardation limited to females: an under-recognized disorder.

Authors:  Ingrid E Scheffer; Samantha J Turner; Leanne M Dibbens; Marta A Bayly; Kathryn Friend; Bree Hodgson; Linda Burrows; Marie Shaw; Chen Wei; Reinhard Ullmann; Hans-Hilger Ropers; Pierre Szepetowski; Eric Haan; Aziz Mazarib; Zaid Afawi; Miriam Y Neufeld; P Ian Andrews; Geoffrey Wallace; Sara Kivity; Dorit Lev; Tally Lerman-Sagie; Christopher P Derry; Amos D Korczyn; Jozef Gecz; John C Mulley; Samuel F Berkovic
Journal:  Brain       Date:  2008-01-29       Impact factor: 13.501

10.  OL-Protocadherin is essential for growth of striatal axons and thalamocortical projections.

Authors:  Masato Uemura; Shinsuke Nakao; Shintaro T Suzuki; Masatoshi Takeichi; Shinji Hirano
Journal:  Nat Neurosci       Date:  2007-08-26       Impact factor: 24.884

View more
  134 in total

1.  Genetic testing in epilepsy: what should you be doing?

Authors:  Ingrid E Scheffer
Journal:  Epilepsy Curr       Date:  2011-07       Impact factor: 7.500

2.  The cadherin superfamily and epileptogenesis: end of the beginning?

Authors:  Edward C Cooper
Journal:  Epilepsy Curr       Date:  2009 May-Jun       Impact factor: 7.500

Review 3.  The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients.

Authors:  Davide Mei; Elena Parrini; Carla Marini; Renzo Guerrini
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

4.  Loss of function of PCDH12 underlies recessive microcephaly mimicking intrauterine infection.

Authors:  Adi Aran; Nuphar Rosenfeld; Ranit Jaron; Paul Renbaum; Shachar Zuckerman; Hila Fridman; Sharon Zeligson; Reeval Segel; Yoav Kohn; Lara Kamal; Moien Kanaan; Yoram Segev; Eyal Mazaki; Ron Rabinowitz; Ori Shen; Ming Lee; Tom Walsh; Mary Claire King; Suleyman Gulsuner; Ephrat Levy-Lahad
Journal:  Neurology       Date:  2016-04-29       Impact factor: 9.910

Review 5.  Epilepsy genetics--past, present, and future.

Authors:  Annapurna Poduri; Daniel Lowenstein
Journal:  Curr Opin Genet Dev       Date:  2011-01-27       Impact factor: 5.578

Review 6.  Cadherins as targets for genetic diseases.

Authors:  Aziz El-Amraoui; Christine Petit
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-01       Impact factor: 10.005

Review 7.  Future directions for epidemiology in epilepsy.

Authors:  Christine Linehan; José F Tellez-Zenteno; Jorge G Burneo; Anne T Berg
Journal:  Epilepsy Behav       Date:  2011-08-04       Impact factor: 2.937

Review 8.  Epileptic encephalopathies: new genes and new pathways.

Authors:  Sahar Esmaeeli Nieh; Elliott H Sherr
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

9.  Rare missense neuronal cadherin gene (CDH2) variants in specific obsessive-compulsive disorder and Tourette disorder phenotypes.

Authors:  Pablo R Moya; Nicholas H Dodman; Kiara R Timpano; Liza M Rubenstein; Zaker Rana; Ruby L Fried; Louis F Reichardt; Gary A Heiman; Jay A Tischfield; Robert A King; Marzena Galdzicka; Edward I Ginns; Jens R Wendland
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

10.  Epilepsy among children and adolescents with autism spectrum disorders: a population-based study.

Authors:  Elina Jokiranta; Andre Sourander; Auli Suominen; Laura Timonen-Soivio; Alan S Brown; Matti Sillanpää
Journal:  J Autism Dev Disord       Date:  2014-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.